KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Return on Invested Capital: 2011-2024

Historic Return on Invested Capital for Supernus Pharmaceuticals (SUPN) over the last 10 years, with Dec 2024 value amounting to 0.06%.

  • Supernus Pharmaceuticals' Return on Invested Capital fell 8.00% to -0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.03%, marking a year-over-year decrease of 8.00%. This contributed to the annual value of 0.06% for FY2024, which is 6.00% up from last year.
  • As of FY2024, Supernus Pharmaceuticals' Return on Invested Capital stood at 0.06%, which was up 2,351.00% from -0.00% recorded in FY2023.
  • Supernus Pharmaceuticals' Return on Invested Capital's 5-year high stood at 0.19% during FY2020, with a 5-year trough of -0.00% in FY2023.
  • In the last 3 years, Supernus Pharmaceuticals' Return on Invested Capital had a median value of 0.04% in 2022 and averaged 0.03%.
  • Per our database at Business Quant, Supernus Pharmaceuticals' Return on Invested Capital decreased by 13bps in 2021 and then grew by 6bps in 2024.
  • Yearly analysis of 5 years shows Supernus Pharmaceuticals' Return on Invested Capital stood at 0.19% in 2020, then decreased by 13bps to 0.06% in 2021, then fell by 2bps to 0.04% in 2022, then fell by 5bps to -0.00% in 2023, then rose by 6bps to 0.06% in 2024.